Sandeep Gedela, Vanita Noronha, Kumar Prabhash. "Clinical outcomes with low-dose lorlatinib in
                    <i>ALK</i>
                    mutation–positive metastatic lung adenocarcinoma: Experience from a tertiary care center in a developing country.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.e20764